United States Government Publishing Office publisher pbl distributor dst United States Congress House of Representatives author aut Government Organization text government publication eng BILLS To amend the Controlled Substances Act with respect to drug scheduling recommendations by the Secretary of Health and Human Services, and with respect to registration of manufacturers and distributors seeking to conduct clinical testing.;Improving Regulatory Transparency for New Medical Therapies Act;H.R. 639 (RH) Bills and Statutes 114_cong_bills legislative 2015-03-17 U.S. Government Publishing Office 2015-03-16 monographic deposited born digital 12 p. Y 1.6: Y 1.4/6: P0b002ee18bb52c69 https://www.govinfo.gov/app/details/BILLS-114hr639rh H.R. 639 021-610-00252-9 000501532 000325573 Congressional bills House bills f:h639_rh.txt https://www.govinfo.gov/app/details/BILLS-114hr639rh https://www.govinfo.gov/content/pkg/BILLS-114hr639rh/html/BILLS-114hr639rh.htm https://www.govinfo.gov/content/pkg/BILLS-114hr639rh/pdf/BILLS-114hr639rh.pdf https://www.govinfo.gov/content/pkg/BILLS-114hr639rh/xml/BILLS-114hr639rh.xml fdlp DGPO 2015-03-17 2023-01-06 BILLS-114hr639rh machine generated eng Joseph R. Pitts United States House of Representatives sponsor spn United States Congress Member Frank Pallone, Jr. United States House of Representatives cosponsor United States Congress Member Gene Green United States House of Representatives cosponsor United States Congress Member Mrs. McMorris Rodgers United States House of Representatives cosponsor United States Congress Member United States Congress House of Representatives Committee on Energy and Commerce associated name asn United States Congress House of Representatives Committee on the Judiciary associated name asn Title 21 Section 355 Title 21 Section 360b Title 21 Section 360ccc-1 Title 21 Section 360ccc-2(c) Title 21 Section 360ccc(d) Title 21 Section 811 Title 21 Section 823 21 U.S.C. 355 21 U.S.C. 360b 21 U.S.C. 360ccc-1 21 U.S.C. 360ccc-2(c) 21 U.S.C. 360ccc(d) 21 U.S.C. 811 21 U.S.C. 823 Title 42 Section 262 42 U.S.C. 262 H. Rept. 114-41 Part I Union Calendar No. 26 hr BILLS-114hr639rh 114 1 HOUSE HOUSE 639 rh rh Improving Regulatory Transparency for New Medical Therapies Act To amend the Controlled Substances Act with respect to drug scheduling recommendations by the Secretary of Health and Human Services, and with respect to registration of manufacturers and distributors seeking to conduct clinical testing. A bill to amend the Controlled Substances Act with respect to drug scheduling recommendations by the Secretary of Health and Human Services, and with respect to registration of manufacturers and distributors seeking to conduct clinical testing, and for other purposes. Mr. Pitts (for himself, Mr. Pallone, and Mr. Gene Green of Texas) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned Additional sponsor: Mrs. McMorris Rodgers Reported from the Committee on Energy and Commerce with amendments The Committee on the Judiciary discharged; committed to the Committee of the Whole House on the State of the Union and ordered to be printed Committee on Energy and Commerce Energy and Commerce Committee on the Judiciary Judiciary Mr. Pitts Joseph R. Pitts Pitts, Joseph R. Joseph Pitts Mr. Pallone Frank Pallone, Jr. Pallone, Frank, Jr. Frank Pallone Mr. Gene Green of Texas Gene Green Green, Gene Mrs. McMorris Rodgers false false